HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MoCRA Check-In: Postscript To My Three Minutes At US FDA's Cosmetics GMP ‘Listening Session’

Executive Summary

EAS Consulting Group’s John Bailey is checking in with HBW Insight periodically in 2023 to offer his views on developments under the US Modernization of Cosmetic Regulations Act of 2022. Here he provides his experience with, and takeaways from, the US FDA’s 1 June virtual “listening session” on good manufacturing practices for cosmetic products.

You may also be interested in...



IBA Connects Members With FDA Compliance Expert As MoCRA Deadlines Loom

The Independent Beauty Association joins with Registrar Corp to provide IBA members with expert resources for preparing for deadlines under the Modernization of Cosmetics Regulation Act.

MoCRA Check-In: FDA Guidance Urgently Needed As Year-End Compliance Deadlines Loom

John Bailey, independent advisor for colors and cosmetics at EAS Consulting Group, is checking in with HBW Insight periodically in 2023 to offer his views on developments under the US Modernization of Cosmetic Regulations Act of 2022. Here he discusses the urgent need for FDA guidance as deadlines creep closer for registration, product listing, safety substantiation, and adverse event reporting.

MoCRA Check-In: Tick, Tock, Tick, Tock…

The compliance clock is ticking! A breakdown of key requirements under new cosmetics regulations and related developments in recent weeks.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel